Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
Description
Harnessing the world's largest real-time data stream on patient experiences, coupled with advanced Artificial Intelligence for analysis and a robust analytics platform that distills patient feedback into clear insights, empowers stakeholders to uncover unmet needs and gain comprehensive insights into the challenges of disease and treatment, ultimately facilitating the design and implementation of more tailored therapies while consistently prioritizing patient care. It can be disheartening to realize that, given existing resource limitations and methodological constraints, achieving optimal patient outcomes can often feel unattainable. By selecting specific diseases, age groups, geographical locations, and any necessary inclusion or exclusion criteria for your research, you can streamline the process of gathering real-world data on a global scale, thereby accessing a vast array of patient populations much more efficiently and without unnecessary complications. This approach not only accelerates research but also enhances the overall understanding of patient experiences in diverse contexts.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform
Vendor Details
Company Name
semalytix
Founded
2015
Country
Germany
Website
www.semalytix.com
Product Features
Product Features
Business Intelligence
Ad Hoc Reports
Benchmarking
Budgeting & Forecasting
Dashboard
Data Analysis
Key Performance Indicators
Natural Language Generation (NLG)
Performance Metrics
Predictive Analytics
Profitability Analysis
Strategic Planning
Trend / Problem Indicators
Visual Analytics